Thursday, 25 August 2016
Last updated 13 hours ago
Feb 6 2008 | 8:44am ET
Hovan Capital Management, a San Francisco-based healthcare focused long/short fund, has hired Ajim Tamboli as a senior portfolio manager of the HCM Market Neutral Fund. Tamboli previously served as a senior small biotechnology analyst at Lehman Brothers in San Francisco.
In addition, Lisa Lee-Hwong, previously with SAC Capital Advisors, has joined the firm to support Tamboli as a portfolio manager focused on emerging science. Current HCM analyst Mikael van Loon will be promoted to the role of portfolio manager in charge of top-down quantitative portfolio risk management.
“Ajim’s experience and interaction with the management teams of portfolio companies coupled with Dr. Lee-Hwong’s scientific research experience will provide a strong positive environment in HCM’s public equity healthcare research department,” said Kurt Hovan, president and CIO of HCM.
“Mikael has mastered HCM’s short portfolio quantitative process and is ready to assume the role of portfolio manager in the fund.”
Hovan Capital Management was established in September 1998.